Literature DB >> 24938874

The role of microRNAs in human breast cancer progression.

WenCheng Zhang1, Jinbo Liu, Guangshun Wang.   

Abstract

Over the past decade, microRNAs (miRNAs) have become a new paradigm of gene regulation. miRNAs are involved in a wide array of carcinogenic processes. Indeed, increasing evidence has shown the importance of miRNAs in cancer, suggesting their possible use as diagnostic, predictive and prognostic biomarkers, leading to miRNA-based anti-cancer therapies, either alone or in combination with current targeted therapies, with the goal of improving cancer treatment responses and increasing cure rates. The advantage of using a miRNA approach is based on the ability to concurrently target multiple effectors of pathways involved in cell proliferation, migration and survival. This review sheds new light on miRNA regulation of genes that play critical roles in the process of malignant transformation and tumour metastasis, the dysregulation of miRNA expression in cancer development and the development of miRNA-based diagnostics and therapeutics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24938874     DOI: 10.1007/s13277-014-2202-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  76 in total

1.  MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.

Authors:  Shanliang Zhong; Wenjing Li; Zhiyuan Chen; Jinjin Xu; Jianhua Zhao
Journal:  Gene       Date:  2013-08-29       Impact factor: 3.688

2.  MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling.

Authors:  Laura Poliseno; Min Sup Song; Su Jung Song; Ugo Ala; Kaitlyn Webster; Christopher Ng; Gary Beringer; Nicolai J Brikbak; Xin Yuan; Lewis C Cantley; Andrea L Richardson; Pier Paolo Pandolfi
Journal:  Cell       Date:  2013-07-03       Impact factor: 41.582

3.  MicroRNA-542-3p inhibits tumour angiogenesis by targeting angiopoietin-2.

Authors:  Ting He; Feifei Qi; Lin Jia; Shan Wang; Nan Song; Lifang Guo; Yan Fu; Yongzhang Luo
Journal:  J Pathol       Date:  2014-02-24       Impact factor: 7.996

4.  miR-153 silencing induces apoptosis in the MDA-MB-231 breast cancer cell line.

Authors:  Maricruz Anaya-Ruiz; Jorge Cebada; Guadalupe Delgado-López; María Luisa Sánchez-Vázquez; José Luis Martín Pérez-Santos
Journal:  Asian Pac J Cancer Prev       Date:  2013

5.  MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.

Authors:  Wen-Dong Bai; Xing-Ming Ye; Meng-Yao Zhang; Hua-Yu Zhu; Wen-Jin Xi; Xun Huang; Jiao Zhao; Bin Gu; Guo-Xu Zheng; An-Gang Yang; Lin-Tao Jia
Journal:  Int J Cancer       Date:  2014-03-03       Impact factor: 7.396

6.  Identification of circulating microRNA signatures for breast cancer detection.

Authors:  Maurice Chan; Chiew Suan Liaw; Shen Mo Ji; Hwee Huang Tan; Chow Yin Wong; Aye Aye Thike; Puay Hoon Tan; Gay Hui Ho; Ann Siew-Gek Lee
Journal:  Clin Cancer Res       Date:  2013-06-24       Impact factor: 12.531

7.  miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.

Authors:  Lin-Zi Li; Chris Zhiyi Zhang; Li-Li Liu; Chun Yi; Shi-Xun Lu; Xuan Zhou; Zhao-Jie Zhang; Yi-Han Peng; Yuan-Zhong Yang; Jing-Ping Yun
Journal:  Carcinogenesis       Date:  2013-10-01       Impact factor: 4.944

8.  Prognostic significance of metastasis-related microRNAs in early breast cancer patients with a long follow-up.

Authors:  Athina Markou; George M Yousef; Efstathios Stathopoulos; Vassilis Georgoulias; Evi Lianidou
Journal:  Clin Chem       Date:  2013-10-16       Impact factor: 8.327

9.  MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).

Authors:  Xuyang Jiao; Lin Zhao; Mengtao Ma; Xuefeng Bai; Miao He; Yuanyuan Yan; Yan Wang; Qiuchen Chen; Xinnan Zhao; Mingyi Zhou; Zeshi Cui; Zhihong Zheng; Enhua Wang; Minjie Wei
Journal:  Breast Cancer Res Treat       Date:  2013-06-19       Impact factor: 4.872

10.  microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.

Authors:  Wenjing Cui; Shuai Zhang; Changliang Shan; Li Zhou; Zhemin Zhou
Journal:  FEBS J       Date:  2013-07-10       Impact factor: 5.542

View more
  33 in total

1.  Upregulation of miR-195 enhances the radiosensitivity of breast cancer cells through the inhibition of BCL-2.

Authors:  Jian Zhu; Qing Ye; Li Chang; Wei Xiong; Qingqing He; Wenhui Li
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer.

Authors:  Lei Huo; Yan Wang; Yun Gong; Savitri Krishnamurthy; Jing Wang; Lixia Diao; Chang-Gong Liu; Xiuping Liu; Feng Lin; William F Symmans; Wei Wei; Xinna Zhang; Li Sun; Ricardo H Alvarez; Naoto T Ueno; Tamer M Fouad; Kenichi Harano; Bisrat G Debeb; Yun Wu; James Reuben; Massimo Cristofanilli; Zhuang Zuo
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

3.  MiRNA-binding site functional polymorphisms in DNA repair genes RAD51, RAD52, and XRCC2 and breast cancer risk in Chinese population.

Authors:  Jingjing Cao; Chenglin Luo; Rui Peng; Qiaoyun Guo; Kaijuan Wang; Peng Wang; Hua Ye; Chunhua Song
Journal:  Tumour Biol       Date:  2016-10-10

4.  Downregulation of miR-362-5p inhibits proliferation, migration and invasion of human breast cancer MCF7 cells.

Authors:  Fang Ni; Zhaohua Gui; Qiang Guo; Zhongqian Hu; Xinyi Wang; Danlei Chen; Siying Wang
Journal:  Oncol Lett       Date:  2015-12-03       Impact factor: 2.967

5.  MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer.

Authors:  Xi-Xue Zhao; Qing-Zhong Yuan; Dong-Po Mu; Di-Wen Sun; Qing-Ao Bo; Guo-Zheng Pan; Guo-Qiang Li; Tao Cui; Peng-Peng Ding; Fa-Ping You; Long Hao; Ming-Xin Wang; Jian Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

6.  MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.

Authors:  Fei Shen; Wen-Song Cai; Zhe Feng; Jiang-Lin Li; Ji-Wei Chen; Jie Cao; Bo Xu
Journal:  Tumour Biol       Date:  2014-11-19

7.  Identifying and targeting angiogenesis-related microRNAs in ovarian cancer.

Authors:  Xiuhui Chen; Lingegowda S Mangala; Linda Mooberry; Emine Bayraktar; Santosh K Dasari; Shaolin Ma; Cristina Ivan; Karem A Court; Cristian Rodriguez-Aguayo; Recep Bayraktar; Sangram Raut; Nirupama Sabnis; Xianchao Kong; Xianbin Yang; Gabriel Lopez-Berestein; Andras G Lacko; Anil K Sood
Journal:  Oncogene       Date:  2019-07-09       Impact factor: 9.867

8.  A Repertoire of MicroRNAs Regulates Cancer Cell Starvation by Targeting Phospholipase D in a Feedback Loop That Operates Maximally in Cancer Cells.

Authors:  Kristen Fite; Lobna Elkhadragy; Julian Gomez-Cambronero
Journal:  Mol Cell Biol       Date:  2016-01-19       Impact factor: 4.272

Review 9.  Role of miRNAs in hypoxia-related disorders.

Authors:  A Gupta; R Sugadev; Y K Sharma; Y Yahmad; P Khurana
Journal:  J Biosci       Date:  2018-09       Impact factor: 1.826

10.  Andrographolide Suppresses the Growth and Metastasis of Luminal-Like Breast Cancer by Inhibiting the NF-κB/miR-21-5p/PDCD4 Signaling Pathway.

Authors:  Junchen Li; Lixun Huang; Zinan He; Minggui Chen; Yi Ding; Yuying Yao; Youfa Duan; Li Zixuan; Cuiling Qi; Lingyun Zheng; Jiangchao Li; Rongxin Zhang; Xiaoming Li; Jianwei Dai; Lijing Wang; Qian-Qian Zhang
Journal:  Front Cell Dev Biol       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.